Skip to main content

Table 2 Comparing the differences of the tumor volumes between the various control groups and the CEA CAR-NK cell therapies group

From: Pharmacologically upregulated carcinoembryonic antigen-expression enhances the cytolytic activity of genetically-modified chimeric antigen receptor NK-92MI against colorectal cancer cells

Parameter

B

Std. Error

95% Wald Confidence Interval

Hypothesis Test

Lower

Upper

Wald Chi-Square

df

Sig.

(Intercept)

109.135

10.4772

88.600

129.670

108.502

1

<  0.001

Group 1 vs. 0

−67.294

12.6052

−91.999

−42.588

28.500

1

<  0.001

Day 19 vs. 0

1138.866

120.2273

903.225

1374.508

89.730

1

<  0.001

Day 15 vs. 0

792.512

54.7220

685.259

899.766

209.743

1

<  0.001

Day 12 vs. 0

523.350

43.5205

438.052

608.649

144.609

1

<  0.001

Day 8 vs. 0

457.892

37.7332

383.936

531.848

147.258

1

<  0.001

Day 4 vs. 0

142.592

37.5555

68.984

216.199

14.416

1

<  0.001

Group x Day 19

−582.990

147.3587

− 871.808

−294.172

15.652

1

<  0.001

Group x Day 15

−415.924

68.5264

− 550.233

−281.615

36.839

1

<  0.001

Group x Day 12

−225.254

51.5495

−326.289

−124.219

19.094

1

<  0.001

Group x Day 8

−262.753

47.9948

− 356.821

− 168.685

29.971

1

<  0.001

Group x Day 4

−57.667

44.7379

−145.352

30.017

1.662

1

0.197

  1. Group = 0 Various Controls Group; =1 CEA CAR-NK Cell Therapies Group